SUPRACOR is Bausch and Lomb’s proprietary presbyopic laser algorithm, licensed for use with the Teneo Model 2 excimer laser. SUPRACOR produces a central corneal zone of variable curvature, resulting in an extended depth of focus. This was a prospective, single-blind, single-centre study conducted at OasisEye Specialists in Kuching, Malaysia. Twenty-six presbyopic patients with myopia received TransPRK in both eyes. To achieve a mini-monovision effect, the dominant eye received PROSCAN aspheric ablation targeting plano, whereas the non-dominant eye received SUPRACOR STRONG targeting -0.75. Primary outcome measures included binocular uncorrected distance, intermediate and near visual acuity. Secondary outcome measures included distance and near stereopsis, spectacle independence and patient satisfaction.

At baseline, mean±standard deviation (SD) age was 43.6±5.3 years. Mean±SD refractive error (S/C) was 3.79±2.52/-0.89±0.58. At an average of 6 months postoperatively, patients had mean binocular UDVA, UIVA (60cm), and UNVA (40cm) of 0.01±0.08, 0.01±0.12, and 0.06±0.16 logMAR, respectively. While 19% (n=5), 42% (n=11), and 39% (n=10) of patients achieved distance (3m) stereo outcomes of 60arcsec, 120arcsec, and ≥180arcsec, 70% of patients (n=18) achieved near (40cm) stereo outcomes of ≤63arcsec. There was no subjective loss of stereopsis. 90% of respondents were completely spectacle independent for driving and intermediate tasks, with 80% reporting complete independence for small print. 80% reported ‘complete’ satisfaction with SUPRACOR.

TransPRK with SUPRACOR results in high spectacle independence and satisfaction, with no subjective loss of stereopsis.